←
Wedbush7,711 posts
Wedbush avatar

Wedbush

@Wedbush

A client-driven financial services firm. Founded in the golden state, with global reach. Member NYSE/FINRA/SIPC

◷ Joined September 2011▧ 1,484 Photos and videos
Wedbush avatar
Wedbush@Wedbush·20h

Roughly half of patients on CGRP migraine treatments still don't see at least a 50% reduction in monthly migraine days. LauraChico, Ph.D. initiates on Mentari Therapeutics ($MTRI) at #OUTPERFORM ($33 PT). MTRI is developing therapies that target a complementary pathway, with initial data expected beginning in mid-2027. #EquityResearch #Biotech #Migraine #Investing

Post attachment
Wedbush avatar
Wedbush@Wedbush·Nov 4

🦖 Life, uh, already found a way. Equity Research Analyst, Martin Fan, Ph.D. initiates on TRex Bio ($TRXB) at #OUTPERFORM ($30 PT). Regulatory T cells were the Ph.D. focus for Martin, and TRXB is advancing more selective approaches to boost them that could limit side effects while maintaining efficacy. Proof-of-concept results for its first candidate are expected in mid-2027. #EquityResearch #Biotech #Immunology #Investing

Post attachment
Wedbush avatar
Wedbush@Wedbush·Oct 29

Wedbush EVP Bob Fitzsimmons joined Illinois Governor @GovPritzker and @Cboe leadership at today’s Opening Bell ceremony, marking an exciting new chapter in market innovation! With Cboe’s KPI Binary Options set to launch on November 16, the occasion highlights how new products are expanding opportunities for market participants. We’re proud to celebrate alongside the Cboe team and look forward to returning for the official launch in November.

0:14
NEXTpredict avatar
⟳ Wedbush retweeted
NEXTpredict@nextpredictio·Oct 21

Sports lead the volume. Where do event contracts go next? Beyond sports, with session partner @Wedbush @HadickM (@dragonfly), @Cboe's JJ Kinahan, Cantor Fitzgerald's Matthew DeCicco and CoinFund's Einar Braathen Thu Oct 22, Main Stage, NYC

Post attachment
Wedbush avatar
Wedbush@Wedbush·Oct 5

Alzheimer's disease affects ~7M Americans, and while approved treatments exist, uptake remains limited by IV infusions and safety concerns. Equity Research Analyst, Laura Chico, Ph.D. initiates on Korsana Biosciences ($KRSA) at #OUTPERFORM ($44 PT), developing a next-gen therapy designed to clear amyloid plaques more deeply and conveniently, with initial data expected mid-2027. #EquityResearch #Biotech #Alzheimers #Neuroscience #Investing

Post attachment
Wedbush avatar
Wedbush@Wedbush·Sep 25

With $META’s Muse launch this week and its growing product lineup, Ygal Arounian, MD, Equity Research, thinks this is just the beginning of the company’s next chapter. He spoke about this and more with @MorganLBrennan on @CNBCMorningCall. cnbc.com/video/2026/09/24/yg…

Wedbush avatar
Wedbush@Wedbush·Sep 24

Food should not hurt. 🍽️ Martin Fan, Ph.D. initiates on Eupraxia ($EPRX) at #OUTPERFORM ($17 PT). EoE, the most frequent cause of food getting stuck in the esophagus, affects 1 in 700 people. Martin sees it as the next big GI indication after IBD. $EPRX is making a proven short-term treatment available long-term. $EPRX joins Martin's growing EoE coverage alongside emerging names $ACRS and $TRAX. #EquityResearch #Biotech #EoE #GastroIntestinal #Investing

Post attachment
Wedbush avatar
Wedbush@Wedbush·Sep 22

🎥: Steven Wahrhaftig, VP, Equity Research, joined @YahooFinance’s @ines_ferre to discuss the cybersecurity companies best positioned for the AI era, the growing need for AI guardrails, and key trends shaping the sector. $CRWD $PANW $TENB $DDOG #Cybersecurity #AI finance.yahoo.com/video/cybe…